DOCSLIB.ORG

Cardiac Surgery

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cardiac Surgery NON-PROFIT ORG. U.S. POSTAGE UAB Insight on Heart and Vascular Disease PAID PERMIT NO. 1256 410 • 500 22nd Street South BIRMINGHAM, AL Insight 1530 3rd ave S ON HEART AND VASCULAR DISEASE birmingham al 35294-0104 UAB Division of Cardiovascular Disease medicine.uab.edu/cardiovasculardisease UAB Division of Cardiothoracic Surgery medicine.uab.edu/cardiothoracicsurgery UAB Section of Vascular Surgery and Endovascular Therapy medicine.uab.edu/vascularsurgery Combined Therapy UAB Ambassador Program for Peripheral Vascular Disease The Ambassador Program gives referring physicians complete access to patient notes, letters, reports, and other data through a Catheter Ablation of secure Web portal. To join this program, please contact Physician Tachycardia Services at 1.800.822.6478. Minimally Invasive Pulmonary Thromboendarterectomy Clinic Cardiac Surgery welcOme 3 cOnTents Uab inSighT Welcome to the first issue of UAB Insight on Heart and Vascular On hearT and Disease, designed to keep you informed about UAB’s leading role in Cardiothoracic Surgery VaScUlar diSeaSe evaluation and treatment of cardiac and vascular diseases. UAB con- FALL 2009 sistently ranks among the top 30 cardiac programs rated in U.S. News Minimally Invasive Cardiac Surgery ... 2 & World Reports, and is a regional, national, and international referral VOlUme 1, nUmber 1 center for cardiac and vascular disease diagnosis and treatment. Adult Congenital Heart Disease ........ 3 With expertise in every major area of heart and vascular diseases, and James Kirklin, MD E D I T O R I N C H I E F as home to the Southeast’s largest and most technologically advanced Pulmonary Thromboendarterectomy Julius Linn, MD Heart and Vascular Center, we offer innovative, scientifically based Clinic .................................................. 4 treatments, providing patients with better outcomes, improved quality of E X E C U T I V E E D I T O R Advanced Heart Failure Therapy and Emily Delzell life, and access to the latest translational research. UAB is Alabama’s major referral center for complex cardiac and vas- Mechanical Support .......................... 5 M A N A G I N G E D I T O R cular disorders and the only hospital in the state that offers heart trans- Peaches Scribner plantation and long-term mechanical circulatory support. UAB is the state’s only facility for surgery for complex congenital heart diseases, Cardiovascular Disease CONTRIBUTOR S and our clinicians also provide care for adults with congenital heart Suzanne Parker Robert Bourge, MD Sleep Apnea and Resistant Peaches Scribner disease. Our vascular surgeons offer advanced surgical and endovascular Hypertension .................................... 6 CREATIVE DIRECTOR stenting technologies for aortic aneurysms, carotid occlusive disease, Ron Gamble peripheral vascular disease, and venous disease. Cardiac Rehabilitation ...................... 7 UAB also provides comprehensive care for pulmonary hypertension, ART DIRECTOR Catheter Ablation of Ventricular including surgery for chronic pulmonary thromboembolism. One of the Jessica Huffstutler world’s most active clinical and research programs, UAB’s Pulmo- Tachycardia ....................................... 8 2 IllUSTRATION nary Vascular Disease Clinic has participated in the development and Echo Medical Media evaluation of virtually all new therapeutic avenues for pulmonary arter- Vascular Surgery ial hypertension in the last 15 years. William Jordan Jr, MD Our minimally invasive and state-of-the-art robotic surgery programs Vascular Medicine............................. 9 offer minimally invasive treatments for coronary artery disease and valve repair and replacement. Published by the Working collaboratively, cardiothoracic surgeons and cardiologists have developed a variety of hybrid UAB Health System Aneurysm Repair ............................ 10 minimally invasive approaches for ischemic heart disease. Our valve program provides percutaneous 500 22nd Street South balloon valvuloplasty for selected cases of aortic, mitral, pulmonic, and tricuspid valve repair using Combined Therapy for Peripheral birmingham, al 35233 10 intracardiac echocardiography, percutaneous repair of atrial septal defects and patent foramen ovale, Vascular Disease ............................. 11 ©2009 by The board of Trustees and alcohol septal ablation for hypertrophic obstructive cardiomyopathy. UAB’s pioneering cardiac electrophysiology service is a regional referral center for electrodiagnos- of The University of Alabama tic and therapeutic care of patients with common and complex arrhythmias, including radiofrequency Heart and Vascular Faculty for the University of Alabama at ablation for atrial fibrillation. Ablation of ventricular tachycardia is now highly successful in carefully Birmingham. Second class postage 8 selected cases of structural heart disease and idiopathic ventricular tachycardia (VT). Patients with Heart and Vascular Faculty .............12 paid by Uab bulk mail dept. implantable cardioverter-defibrillators who experience repeated shocks can benefit from VT ablation, Postmaster: address changes to: as can patients with idiopathic VT or dilated cardiomyopathy-associated VT. UAB physicians also offer advanced therapies for heart failure, resistant hypertension, and hyper- UAB Insight lipidemias, as well as unique diagnostic echocardiography, cardiographics, and imaging studies. UAB inSighT Online 410 • 500 22nd Street South Our collaborative approach to heart and vascular diseases is designed to provide timely, seamless 1530 3rd ave S care that serves our patients and referring physicians, to everyone’s benefit. We look forward to work- Visit UAB Insight online (uabmedicine.org/insight) to request a second issue of UAB Insight on birmingham al 35294-0104 ing with you. Heart and Vascular Disease, request our other referring physician magazines, or to sign up for Or call the toll-free miST line: electronic delivery. The site also offers breaking news, referring physician resources, and new 1.800.822.6478 faculty announcements. It features videocasts of our physicians discussing the latest procedures [email protected] available at UAB, CME opportunities, information on the Ambassador Program for referring James K. Kirklin, MD Robert C. Bourge, MD William D. Jordan Jr, MD physicians, and more. Cardiothoracic Surgery Cardiothoracic Surgery Robotic-Assisted and Minimally Adult Congenital Heart Disease Clinic Invasive Cardiac Surgeries A Continuum of Multidisciplinary Care Is Crucial Riding the Wave of the Future Approximately 800,000 US adults are enced interventional cardiolo- living with congenital heart disease (CHD). gists, electrophysiologists, surgeons, perfusionists, an- Cardiac procedures comprise a large “Hybrid procedures offer exponential perform all complex repairs with the system, Advances in diagnosis and therapy have esthesiologists, intensivists, portion of ever-increasing options for mini- benefits to patients who may be able to including chordal placement, leaflet resec- substantially reduced CHD mortality rates, obstetricians, operating mally invasive and robotic-assisted surgery avoid multiple surgeries, extended hos- tion, and ring annuloplasty. and large numbers of young people with room and intensive care at UAB, one of five pilot institutions desig- pital stays, and downtime from work. “This totally endoscopic approach al- complex diagnoses, such as tetralogy of unit staff, and social nated to train residents on the da Vinci ro- It is a quality of life issue,” he says. lows patients to return to work in about 2 Fallot, transposition, and single ventricle, services staff. UAB’s bot, a minimally invasive surgical system. “Patients request the robotic approach weeks with much less discomfort, blood survive into adulthood. The number of Adult Congenital Robotic-assisted surgical techniques, because they can return to work in just 2 loss, and morbidity than with traditional adults with CHD has surpassed the number Heart Disease Clinic’s performed at UAB since 2001, offer at- weeks — rather than 8 — with no activity procedures.” He performs aortic valve of children with the condition. Many of synergistic care ad- tractive advantages over traditional ap- restrictions. They appreciate the superior replacement as a minimally invasive proce- these adults have residual heart problems dresses all aspects of proaches. Hybrid surgeries, which address cosmetic effects: no large chest scar and dure using a 1- to 2-inch parasternal inci- requiring ongoing follow-up and treatment CHD. “Mapping out multivessel disease, are the wave of the no scar down their leg.” sion with no sternal incisions. by specialists. an appropriate treatment future, says UAB cardiothoracic surgeon Akins also has begun a program for total Other procedures Akins does robotically As they age, these adults are at risk for course for patients with Christopher W. Akins, MD. endoscopic bypass surgery, or “port access are atrial septal defect repair, tricuspid CHD as well as the same adult illnesses that complex disease requires Compared with traditional open proce- surgery,” which requires one to four very valve repair, combination mitral and tri- affect the general population. Consequently, extensive experience in dures, robotic-assisted surgeries have many small (5-10 mm) incisions in the chest cuspid valve repair, and ablation of atrial comprehensive care must address congenital pediatric and adult cardiol- design. , contributed to this illustration’s advantages: smaller incisions, reduced
Load more

Recommended publications
  • CADTH Technology Report
    Canadian Agency for Agence canadienne Drugs and Technologies des médicaments et des in Health technologies de la santé CADTH Technology Report Issue 128 Ablation Procedures for Rhythm Control in September 2010 Patients with Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses Supporting Informed Decisions Until April 2006, the Canadian Agency for Drugs and Technologies in Health (CADTH) was known as the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Publications can be requested from: CADTH 600-865 Carling Avenue Ottawa ON Canada K1S 5S8 Tel.: 613-226-2553 Fax: 613-226-5392 Email: [email protected] or downloaded from CADTH’s website: http://www.cadth.ca Cite as: Assasi N, Blackhouse G, Xie F, Gaebel K, Robertson D, Hopkins R, Healey J, Roy D, Goeree R. Ablation Procedures for Rhythm Control in Patients with Atrial Fibrillation: Clinical and Cost-Effectiveness Analyses [Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2010 (Technology report; no. 128). [cited 2010-09-17]. Available from: http://www.cadth.ca/index.php/en/hta/reports-publications/search?&type=16 Production of this report is made possible by financial contributions from Health Canada and the governments of Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Prince Edward Island, Saskatchewan, and Yukon. The Canadian Agency for Drugs and Technologies in Health takes sole responsibility for the final form and content of this report. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Reproduction of this document for non-commercial purposes is permitted provided appropriate credit is given to CADTH.
    [Show full text]
  • Understanding Cardiomyopathy: Practical Guidelines
    Chapter 30 Understanding Cardiomyopathy: Practical Guidelines Asha Moorthy, Jain T Kallarakkal HYPERTROPHIC CARDIOMYOPATHY genes predominate in frequency. Beta-myosin heavy chain (the first identified), myosin-binding protein C and cardiac troponin T Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder probably comprise more than one half of the genotyped patients to caused by mutations in 1 of the 12 sarcomeric or nonsarcomeric date. Seven other genes each account for fewer cases: regulatory and genes and is recognized as the most common cause of sudden cardiac essential myosin light chains, titin, alpha-tropomyosin, alpha-actin, death (SCD) in the young and an important substrate for disability cardiac troponin I and alpha-myosin heavy chain. at any age. It affects men and women equally and occurs in many races and countries. The clinical diagnosis of HCM is established most easily and reliably with two-dimensional echocardiography by Clinical Course demonstrating left ventricular hypertrophy (LVH) which is typically asymmetric in distribution, and showing virtually any diffuse or Adverse clinical course proceeds along one or more of the following segmental pattern of left ventricular (LV) wall thickening. LV wall pathways, which ultimately dictate treatment strategies: (1) high thickening is associated with a nondilated and hyperdynamic risk for premature, sudden and unexpected death; (2) progressive chamber, in the absence of any other cardiac or systemic disease symptoms like exertional dyspnea, chest pain and impaired
    [Show full text]
  • Using Vectorcardiography in Cardiac Resynchronization Therapy
    Using Vectorcardiography In Cardiac Resynchronization Therapy By L.Lindeboom BMTE 10.19 Report Internship Catharina Hospital Eindhoven Eindhoven University of Technology Supervisors Dr. Ir. M. van ‘t Veer Dr. B.M. van Gelder Dr. Ir. M.C.M. Rutten Prof. Dr. N.H.J. Pijls 1 Abstract (English) The conductive system of the heart may be affected by a heart disease due to direct damage of the Purkinje bundle branches or by a changed geometry in a dilated heart. As a result the electrical activation impulse will no longer travel across the preferred pathway and a loss of ventricular synchrony, prolonged ventricular depolarization and a corresponding drop in the cardiac output is observed. During cardiac resynchronization therapy (CRT) a biventricular pacemaker is implanted, which is used to resynchronise the contraction between different parts of the myocardium. Optimize pacing lead placement and CRT device programming, is important to maximize the benefit for the selected patients. The use of vectorcardiography (VCG) for CRT optimization is investigated. In current clinical practice a 12-lead electrocardiogram (ECG) is used to measure the electric cardiac activity of a patient. Each cell in the heart can be represented as an electrical dipole with differing direction during a heartbeat. A collection of all cellular dipoles will result in a single dipole, the cardiac electrical vector. Spatial visualization of the intrinsically three- dimensional phenomena, using VCG, might allow for an improved interpretation of the electric cardiac activity as compared to the one dimensional projections of a scalar ECG. The VCG loops of one healthy subject and two subjects with a left bundle branch block (LBBB) and two subjects with a right bundle branch block (RBBB) are qualitatively described.
    [Show full text]
  • Severe Mitral Annular Calcification
    JACC: CARDIOVASCULAR IMAGING VOL. 9, NO. 11, 2016 ª 2016 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER http://dx.doi.org/10.1016/j.jcmg.2016.09.001 STATE-OF-THE-ART PAPERS Severe Mitral Annular Calcification Multimodality Imaging for Therapeutic Strategies and Interventions Mackram F. Eleid, MD, Thomas A. Foley, MD, Sameh M. Said, MD, Sorin V. Pislaru, MD, PHD, Charanjit S. Rihal, MD, MBA ABSTRACT Mitral annular calcification (MAC) is a chronic degenerative process associated with advanced age and conditions predisposing to left ventricular hypertrophy. Assessment of mitral valve disease in patients with severe MAC can be a challenge. When severe MAC results in mitral stenosis or regurgitation, multimodality imaging with 2-dimensional, 3-dimensional, and Doppler echocardiography and cardiac computed tomography angiography can delineate the severity and pathoanatomic features to help guide therapeutic strategies. New approaches using computer-assisted simulation of transcatheter valves and novel percutaneous and surgical techniques are being used to devise effective alternative strategies to conventional mitral valve replacement in this high-risk group of patients. (J Am Coll Cardiol Img 2016;9:1318–37) © 2016 by the American College of Cardiology Foundation. itral annular calcification (MAC) is a being investigated, offering hope for this challenging M chronic degenerative process that, when group of patients. severe, can result in mitral stenosis (MS) and/or mitral regurgitation (MR). The prevalence of PATHOPHYSIOLOGY OF MAC significant MS due to severe MAC is increasing in the developed world due to the growing population MAC is a result of slowly progressive calcification of ofelderlypatientsandriskfactorssuchashyperten- the fibrous mitral annulus (Figure 1) (1).
    [Show full text]
  • Magnetic Resonance Imaging of Non‑Ischemic Cardiomyopathies: a Pictorial Essay
    Editor-in-Chief: Vikram S. Dogra, MD OPEN ACCESS Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USA HTML format Journal of Clinical Imaging Science For entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.asp www.clinicalimagingscience.org PICTORIAL ESSAY Magnetic Resonance Imaging of Non‑ischemic Cardiomyopathies: A Pictorial Essay Cristina I Olivas‑Chacon, Carola Mullins, Kevan Stewart, Nassim Akle, Jesus E Calleros, Luis R Ramos‑Duran Department of Radiology, Texas Tech University Health Science Center El Paso, El Paso, Texas, USA Address for correspondence: Dr. Cristina Ivette Olivas Chacon, ABSTRACT Department of Radiology, 4800 Alberta Avenue, El Paso, Non-ischemic cardiomyopathies are defined as either primary or secondary diseases of Texas ‑ 79905, USA. the myocardium resulting in cardiac dysfunction. While primary cardiomyopathies are E‑mail: [email protected] confined to the heart and can be genetic or acquired, secondary cardiomyopathies show involvement of the heart as a manifestation of an underlying systemic disease including metabolic, inflammatory, granulomatous, infectious, or autoimmune entities. Non-ischemic cardiomyopathies are currently classified as hypertrophic, dilated, restrictive, or unclassifiable, including left ventricular non-compaction. Cardiovascular Magnetic Resonance Imaging (CMRI) not only has the capability to assess cardiac morphology and function, but also the ability to detect edema, hemorrhage, fibrosis, and intramyocardial deposits,
    [Show full text]
  • Targeting Alcohol Septal Ablation in Patients with Obstructive
    Journal of Clinical Medicine Article Targeting Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy Candidates for Surgical Myectomy: Added Value of Three-Dimensional Intracoronary Myocardial Contrast Echocardiography Giovanni La Canna 1,*, Iside Scarfò 1, Irina Arendar 1, Antonio Colombo 2, Lucia Torracca 3, Davide Margonato 4, Matteo Montorfano 4 and Ottavio Alfieri 5 1 Applied Diagnostic Echocardiography Unit, IRCCS Humanitas Clinical and Research Center, 20089 Rozzano, Italy; [email protected] (I.S.); [email protected] (I.A.) 2 Interventional Cardiology Unit, IRCCS Humanitas Clinical and Research Center, 20089 Rozzano, Italy; [email protected] 3 Cardiac Surgery, IRCCS Humanitas Clinical and Research Center, 20089 Rozzano, Italy; [email protected] 4 Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; [email protected] (D.M.); [email protected] (M.M.) 5 Cardiac Surgery Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; ottavio.alfi[email protected] * Correspondence: [email protected]; Tel.: +39-33-5674-4319 Citation: La Canna, G.; Scarfò, I.; Abstract: Background: Myocardial contrast two-dimensional echocardiography (MC-2DE) is widely Arendar, I.; Colombo, A.; Torracca, L.; Margonato, D.; Montorfano, M.; used to address alcohol septal ablation (ASA) in obstructive hypertrophic cardiomyopathy (HCM). Alfieri, O. Targeting Alcohol Septal Owing to its limited cut-planes, MC-2DE may inaccurately identify the contrast misplacement Ablation in Patients with Obstructive associated with an unsuccessful or complicated ASA outcome. Objective: The aim of this study Hypertrophic Cardiomyopathy was to assess the added value of myocardial contrast three-dimensional echocardiography (MC- Candidates for Surgical Myectomy: 3DE) compared with MC-2DE to identify the appropriate matching between the target septal zone Added Value of Three-Dimensional (TSZ) and coronary artery branch for safe and long-term effective ASA in HCM patients.
    [Show full text]
  • Hypertrophic Cardiomyopathy 2011 Pocket Guide
    ACCF/AHA Pocket Guideline Adapted from the 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy November 2011 Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons © 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc. The following material was adapted from the 2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (J Am Coll Cardiol 2011;XX:XX–XX). This pocket guideline is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource. org) and the American Heart Association (my.americanheart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, e-mail: [email protected]; phone: 212-633-3813; fax: 212-633-3820. Permissions: Multiple copies, modification, alteration, enhancement, and/ ordistribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier’s permission department at [email protected]. Contents 1. Introduction .........................................................................................3 2. Clinical Definition ................................................................................6 3. Genetic
    [Show full text]
  • 2009 - 2010 Quality Report EXECUTIVE MEDICAL DIRECTOR’S LETTER
    OREGON HEART & VASCULAR INSTITUTE HEART & VASCULAR OREGON 2009 - 2010 Quality Report EXECUTIVE MEDICAL DIRECTOR’S LETTER Exceptionally High Quality and Wide Range of Clinical Care On behalf of my colleagues dedicated to heart and vascular health, I am pleased to present this inaugural 2009-2010 Quality Report of the Oregon Heart & Vascular Institute at Sacred Heart Medical Center. This report details the exceptionally high quality and wide range of clinical care we offer at Oregon Heart & Vascular Institute. Our heart and vascular programs are top- rated in the state and nationally. We aim for excellence in all areas and techniques so that we can achieve the best possible results. Our achievements are worth sharing: • We are very proud of our dramatic improvements in treating AMI patients. At 2.06 percent, Sacred Heart’s heart attack mortality rate is now among the very best in the country. Our mortality rate is roughly half that predicted for our population by the federal Centers for Medicare and Medicaid Services. Our heart attack mortality rate is roughly a quarter of what it was six years ago — meaning many lives saved. • In 2009, our cardiothoracic surgery program was recognized with the highest rating from the Society of Thoracic Surgeons — a rating earned by only 11.7% of their 955 participants. • Our vascular surgeons and interventional radiologists continue to lead the way What’s Inside regionally in providing patients with a range of effective and minimally invasive Overview ..............................3 treatments for emergent problems and elective procedures. Coronary Artery In August 2008, the Oregon Heart & Vascular Institute opened a 156,000-square-foot, Disease .................................9 five-story facility at Sacred Heart Medical Center’s state-of-the-art RiverBend campus Core Measures .........................10 in Springfield.
    [Show full text]
  • No.5 November 2014 1
    No.5 November 2014 1 CARDIOMETRY Basic and applied research. Theory, practice, therapy, engineering, philosophy & methodology. ISSN 2304-7232 e-Journal www.cardiometry.net Editorial board EDITOR-IN-CHIEF Prof. V. Zernov, RUS EXECUTIVE EDITORS Prof. M. Rudenko, RUS EDITORIAL ADVISORY BOARD Prof. Y. Gulyaev, RUS Prof. H.R. Horvitz, USA Prof. R. Baevsky, RUS Prof. P. Mansfield, GBR Prof. S. Chefranov, RUS Dr. C. Müller, AUT Dr. S. Kolmakov, FIN Dr. O. Voronova, RUS Prof. J. Moreno-López, SWE Prof. V. Vecherkin, RUS Prof. V. Polikarpov, RUS Prof. S. Zaguskin, RUS Prof. G. Stupakov, RUS Dr. Zied ben El hadj, TUN Prof. V. Tyutyunnik, RUS Dr. Marwan Refaat, LBN Prof. B. Leonov, RUS Dr. Chandra Mani Adhikari, NPL Prof. Mohammad Aleem, EGY Dr. Saad Al Bugami, SAU Dr. Alberto Alfie, ARG Prof. Alejandro Barbagelata, USA Dr. Pablo Avanzas, ESP Dr. Nancy Aggeli, GRC Dr. Marko Banovic, SRB Prof. Dimitrios Karakitsos, USA 2 www.cardiometry.net Founded and published by Russian New University www.rosnou.ru Editorial Front Office: Radio Street, 22 Moscow Russia 105005 Phone/Fax: +7 (495) 925-03-83 Editorial Back Office: Alexandrovskaya Street, 47 Taganrog Russia 347900 Phone/Fax: +7 (8634) 31-24-03 E-mail: [email protected] An official peer-reviewed journal. Frequency: 2 issues/year. First issue: 2012. Managing editor: T. Kharchenko. Datawarehouse manager: S. Rudenko. Design developer: Т. Fedosova. Content manager: K. Kamyshev © All rights reserved. No.5 November 2014 3 CARDIOMETRY No.5 November 2014 Current status and prospects for e-Cardiology & e-Health development based on materials 6 of the European Congress on e-Cardiology & e-Health, Bern, 29-31 October, 2014 Goran Krstacic New points on ECG: a new valuable source of information 7 Mikhail Y.
    [Show full text]
  • Use of a Biophysical Model of Atrial Fibrillation in The
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library European Journal of Cardio-thoracic Surgery 32 (2007) 90—95 www.elsevier.com/locate/ejcts Use of a biophysical model of atrial fibrillation in the interpretation of the outcome of surgical ablation procedures§ Patrick Ruchat a,*, Lam Dang b,Ju¨rg Schlaepfer c, Nathalie Virag d, Ludwig Karl von Segesser a, Lukas Kappenberger c a Department of Cardiovascular Surgery, University Hospital, Lausanne, Switzerland b Signal Processing Institute, E´cole Polytechnique Fe´de´rale de Lausanne, Switzerland c Department of Cardiology, University Hospital, Lausanne, Switzerland d Medtronic Europe, Tolochenaz, Switzerland Received 5 September 2006; received in revised form 13 February 2007; accepted 20 February 2007; Available online 8 April 2007 Abstract Objective: To determine the adequacy of ‘in silico’ biophysical models of atrial fibrillation (AF) in the design of different ablation line patterns. Background: Permanent AF is a severe medical problem for which (surgical) ablation is a possible treatment. The ideal ablation pattern remains to be defined. Methods: Forty-six consecutive adult patients with symptomatic permanent drug refractory AF underwent mitral surgery combined with non-transmural, (n = 20) and transmural (n = 26) radiofrequency Minimaze. The fraction of ‘in vivo’ conversions to sinus rhythm (SR) in both groups was compared with the performance of the fraction of ‘in silico’ conversions observed in a biophysical model of permanent AF. The simulations allowed us to study the effectiveness of incomplete and complete ablation patterns. A simulated, complete, transmural Maze III ablation pattern was applied to 118 different episodes of simulated AF set-up in the model and its effectiveness was compared with the clinical results reported by Cox.
    [Show full text]
  • Euro-Asian Journal of Surgery and Medicine
    Euro-Asian Journal of Surgery and Medicine 13th Annual Meeting of the Euro-Asian Bridge Society for Cardiovascular Surgery joint with The 3rd Symposium of Pediatric Cardiology & Cardiac Surgery https://www.eab2017romania.org https://www.euroasianbridge.org http://www.eajsm.org Euro-Asian Journal of Surgery and Medicine Volume I No. 1 September 2017 CONTENTS Welcome message 1 Editorial Board 3 Meeting Programme 5 Meeting Abstracts 37 Author Index 129 Call for Papers 135 Sponsors 137 SCIENTIFIC PARTNERS Submit your paper and access online articles at http://www.eajsm.org Contact us with any questions and for information at: [email protected] Euro-Asian Journal of Surgery and Medicine 2017; I(1):1 Esteemed guests and collaborators, Dearest friends and colleagues, Ladies and gentlemen, It brings me great honor and joy to offer you a warm welcome at the 13th edition of the Euro Asian Bridge Society's annual congress taking place here, in the lovely capital of the province of Moldova, the city of Iasi. My friends, we are meeting now during worrying times, in a world troubled by complex international relations, and a redefining of the socio-economic and political state of mind. It is a time defined by globalization, that has given rise to societies governed by increasing demands of excellency in all quarters of life. It is also a time in which clear dialogue between social partners - (such as) Health Ministries, Governments, Universities and medical societies- has become not only a necessity but also our greatest asset in the struggle for improving healthcare and thusly the quality of life.
    [Show full text]
  • Heart Institute Annual Report 2021 (PDF)
    2021 ANNUAL REPORT HEART 02 Welcome 04 Advanced Heart Failure 06 Coronary Artery Disease 08 Congenital Heart Disease 10 Valvular Heart Disease 12 Electrophysiology 14 Health Equity 16 Aortic Disease 18 Metrics 26 Directory About the Art The artwork in this report stems from a collaboration between Seattle-based artist Kanako Abe and Joanna Chikwe, MD, chair of the Department of Cardiac Surgery at Cedars-Sinai, who illustrates her own textbooks. Abe creates hand-cut, intricate paper pieces, using the Japanese art of Ise katagami—a traditional technique employed to create patterns on kimono fabric. Abe used Ise katagami cutting tools, similar to a surgical scalpel, to create these images on paper, which all include symbols of cardiovascular care. “Our program is one of the most successful and innovative in the U.S because of our unique expertise in state-of-the-art care across the entire spectrum of cardiovascular disease.” Joanna Chikwe, MD Irina and George Schaeffer Distinguished Chair in Cardiac Surgery in honor of Alfredo Trento, MD, Chair of the Department of Cardiac Surgery and Professor of Cardiac Surgery “With the incredible breadth of expertise at the Smidt Heart Institute, we are not only developing new technologies to treat disease, we are also advancing the science of population health so we can predict who is at risk and do more to prevent disease in our most vulnerable populations.” Christine M. Albert, MD, MPH Lee and Harold Kapelovitz Distinguished Chair in Cardiology, Chair of the Department of Cardiology and Professor of Cardiology 2 Smidt Heart Institute | cedars-sinai.org/heart Dear Colleague, It is with considerable pride that I share our annual report for 2021.
    [Show full text]